Skip to content

Dexmedetomidine in Pediatric Tonsillectomy

Dose Response Relationship of Dexmedetomidine in Decreasing Post Operative Analgesic Requirements in the Pediatric Tonsillectomy Patient

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01057381
Enrollment
109
Registered
2010-01-27
Start date
2005-08-31
Completion date
2010-12-31
Last updated
2021-07-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pediatric Adenotonsillectomy, Post Operative Analgesia

Keywords

Adenotonsillectomy, Postoperative analgesia, Pediatrics

Brief summary

The hypothesis of this study is that the administration of an intra-operative dose of dexmedetomidine will result in adequate analgesia without respiratory depression thereby resulting in an early discharge from the post anesthetic care unit following adenotonsillectomy.

Detailed description

Dexmedetomidine, an alpha 2 agonist provides some analgesia without respiratory depression. Children undergoing tonsillectomy and adenoidectomy occasionally have episodes of respiratory obstruction in the recovery room following administration of opioids. As dexmedetomidine provides some analgesia without respiratory depression,an intra-operative dose of dexmedetomidine may provide adequate analgesia without significant side effects thereby allowing for quick post operative recovery.

Interventions

DRUGDexmedetomidine 0.75 mcg/kg

Single intra-operative administration of dexmedetomidine 0.75 mcg/kg over 10 minutes for analgesia.

DRUGMorphine 50 mcg/kg

Single intra-operative administration of morphine 50 mcg/kg over 10 minutes for analgesia

DRUGMorphine 100 mcg/kg

Single intra-operative dose of morphine 100 mcg/kg over 10 minutes for analgesia

DRUGDexmedetomidine 1 mcg/kg

Single intra-operative administration of dexmedetomidine 1 mcg/kg over 10 minutes for analgesia

Sponsors

Baylor College of Medicine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
3 Years to 17 Years
Healthy volunteers
Yes

Inclusion criteria

* Children between ages 3 and 17 years with American Society of Anesthesiology classification 1 or 2.

Exclusion criteria

* Children less than 3 years * Children with uncorrected cardiac lesions * Children with heart block or liver impairment * Children with American Society of Anesthesiology Class 3 or 4.

Design outcomes

Primary

MeasureTime frame
Amount of Post-Operative Rescue Morphine Required for AnalgesiaFrom admission to discharge from PACU, up to 1 hour

Secondary

MeasureTime frameDescription
Morphine Rescue Doses Needed by ParticipantsFrom admission to discharge from PACU, up to 1 hourSubjects with a Children's Hospital of Eastern Ontario Pain Scale score greater than 8 received rescue morphine doses of 25 ug/kg IV at 10-minute intervals until the score was less than 8. Minimum and Maximum values: minimum score: 4 & maximum score: 13. The higher the score ( \> 8), the greater the pain appreciated by the patient.
Duration of Oxygen SupplementationFrom admission to PACU until room air saturations greater than or equal to 95% for 5 minutesThe subjects were then transported to the PACU with supplemental oxygen. Oxygen administration was continued after extubation until the patient was awake and could sustain room air saturations greater than 95% for 5 minutes. Duration of oxygen requirement was recorded as the time from tracheal extubation to cessation of oxygen supplementation in the PACU.
Time to PACU Discharge ReadinessFrom admission to discharge from PACU, no time limitPatients were considered ready for discharge from the PACU when they attained an Aldrete score of 9 or more and were free from pain, nausea, and vomiting. Aldrete score ranges form 0 to 10 and patients greater than 8 are deemed satisfactory for discharge from the PACU
Number of Participants With Emergence AgitationFrom admission to discharge from PACU, no time limitPatients in the PACU who were crying, restless, disoriented, unresponsive to the parent's voice, with non-purposeful thrashing movements requiring additional personnel to prevent bodily harm, and inconsolable even after parental presence, rescue analgesia and additional measures of comfort were considered to have emergence agitation.
Number of Participants With Postoperative ComplicationsFrom admission to discharge from PACU, up to 1 hourPost-operative complications including emesis, prolonged oxygen requirement or post- tonsillectomy bleed assessed up to 1 hour in PACU

Countries

United States

Participant flow

Participants by arm

ArmCount
Dexmedetomidine 0.75 mcg/kg
Intraoperative administration for analgesia. Dexmedetomidine 0.75 mcg/kg: Single intra-operative administration of dexmedetomidine 0.75 mcg/kg over 10 minutes for analgesia.
26
Dexmedetomidine 1mcg/kg
Intra-operative administration of dexmedetomidine 1 mcg/kg for analgesia Dexmedetomidine 1 mcg/kg: Single intra-operative administration of dexmedetomidine 1 mcg/kg over 10 minutes for analgesia
27
Morphine 50 mcg/kg
Intra-operative administration of morphine 50 mcg/kg for analgesia Morphine 50 mcg/kg: Single intra-operative administration of morphine 50 mcg/kg over 10 minutes for analgesia
30
Morphine 100mcg/kg
Intra-operative administration of morphine 100mcg/kg for analgesia Morphine 100 mcg/kg: Single intra-operative dose of morphine 100 mcg/kg over 10 minutes for analgesia
26
Total109

Baseline characteristics

CharacteristicDexmedetomidine 0.75 mcg/kgDexmedetomidine 1mcg/kgMorphine 50 mcg/kgMorphine 100mcg/kgTotal
Age, Categorical
<=18 years
26 Participants27 Participants30 Participants26 Participants109 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
0 Participants0 Participants0 Participants0 Participants0 Participants
Duration of Anesthesia48.2 minutes
STANDARD_DEVIATION 19.3
44.7 minutes
STANDARD_DEVIATION 10.8
43.3 minutes
STANDARD_DEVIATION 9.7
49.6 minutes
STANDARD_DEVIATION 13.3
46.3 minutes
STANDARD_DEVIATION 13.7
Duration of Surgery22.0 minutes
STANDARD_DEVIATION 8.4
21.3 minutes
STANDARD_DEVIATION 9.7
22.8 minutes
STANDARD_DEVIATION 7.6
26.0 minutes
STANDARD_DEVIATION 9.5
23.0 minutes
STANDARD_DEVIATION 8.9
Race and Ethnicity Not Collected0 Participants
Region of Enrollment
United States
26 participants27 participants30 participants26 participants109 participants
Sex: Female, Male
Female
18 Participants16 Participants15 Participants16 Participants65 Participants
Sex: Female, Male
Male
8 Participants11 Participants15 Participants10 Participants44 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
deaths
Total, all-cause mortality
0 / 260 / 270 / 300 / 26
other
Total, other adverse events
0 / 260 / 270 / 300 / 26
serious
Total, serious adverse events
0 / 260 / 270 / 300 / 26

Outcome results

Primary

Amount of Post-Operative Rescue Morphine Required for Analgesia

Time frame: From admission to discharge from PACU, up to 1 hour

ArmMeasureValue (MEAN)Dispersion
Dexmedetomidine 0.75 mcg/kgAmount of Post-Operative Rescue Morphine Required for Analgesia45.2 ug/kgStandard Deviation 30.8
Dexmedetomidine 1mcg/kgAmount of Post-Operative Rescue Morphine Required for Analgesia37.0 ug/kgStandard Deviation 25.4
Morphine 50 mcg/kgAmount of Post-Operative Rescue Morphine Required for Analgesia43.3 ug/kgStandard Deviation 23.6
Morphine 100mcg/kgAmount of Post-Operative Rescue Morphine Required for Analgesia36.5 ug/kgStandard Deviation 31
Secondary

Duration of Oxygen Supplementation

The subjects were then transported to the PACU with supplemental oxygen. Oxygen administration was continued after extubation until the patient was awake and could sustain room air saturations greater than 95% for 5 minutes. Duration of oxygen requirement was recorded as the time from tracheal extubation to cessation of oxygen supplementation in the PACU.

Time frame: From admission to PACU until room air saturations greater than or equal to 95% for 5 minutes

ArmMeasureValue (MEAN)Dispersion
Dexmedetomidine 0.75 mcg/kgDuration of Oxygen Supplementation17 minutesStandard Deviation 11
Dexmedetomidine 1mcg/kgDuration of Oxygen Supplementation19 minutesStandard Deviation 12
Morphine 50 mcg/kgDuration of Oxygen Supplementation20 minutesStandard Deviation 19
Morphine 100mcg/kgDuration of Oxygen Supplementation18 minutesStandard Deviation 14
Secondary

Morphine Rescue Doses Needed by Participants

Subjects with a Children's Hospital of Eastern Ontario Pain Scale score greater than 8 received rescue morphine doses of 25 ug/kg IV at 10-minute intervals until the score was less than 8. Minimum and Maximum values: minimum score: 4 & maximum score: 13. The higher the score ( \> 8), the greater the pain appreciated by the patient.

Time frame: From admission to discharge from PACU, up to 1 hour

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Dexmedetomidine 0.75 mcg/kgMorphine Rescue Doses Needed by Participants1 dose2 Participants
Dexmedetomidine 0.75 mcg/kgMorphine Rescue Doses Needed by Participants>1 dose18 Participants
Dexmedetomidine 0.75 mcg/kgMorphine Rescue Doses Needed by Participants0 dose6 Participants
Dexmedetomidine 1mcg/kgMorphine Rescue Doses Needed by Participants0 dose3 Participants
Dexmedetomidine 1mcg/kgMorphine Rescue Doses Needed by Participants>1 dose10 Participants
Dexmedetomidine 1mcg/kgMorphine Rescue Doses Needed by Participants1 dose14 Participants
Morphine 50 mcg/kgMorphine Rescue Doses Needed by Participants1 dose13 Participants
Morphine 50 mcg/kgMorphine Rescue Doses Needed by Participants0 dose1 Participants
Morphine 50 mcg/kgMorphine Rescue Doses Needed by Participants>1 dose16 Participants
Morphine 100mcg/kgMorphine Rescue Doses Needed by Participants0 dose4 Participants
Morphine 100mcg/kgMorphine Rescue Doses Needed by Participants>1 dose8 Participants
Morphine 100mcg/kgMorphine Rescue Doses Needed by Participants1 dose14 Participants
Secondary

Number of Participants With Emergence Agitation

Patients in the PACU who were crying, restless, disoriented, unresponsive to the parent's voice, with non-purposeful thrashing movements requiring additional personnel to prevent bodily harm, and inconsolable even after parental presence, rescue analgesia and additional measures of comfort were considered to have emergence agitation.

Time frame: From admission to discharge from PACU, no time limit

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Dexmedetomidine 0.75 mcg/kgNumber of Participants With Emergence Agitation5 Participants
Dexmedetomidine 1mcg/kgNumber of Participants With Emergence Agitation4 Participants
Morphine 50 mcg/kgNumber of Participants With Emergence Agitation4 Participants
Morphine 100mcg/kgNumber of Participants With Emergence Agitation1 Participants
Secondary

Number of Participants With Postoperative Complications

Post-operative complications including emesis, prolonged oxygen requirement or post- tonsillectomy bleed assessed up to 1 hour in PACU

Time frame: From admission to discharge from PACU, up to 1 hour

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Dexmedetomidine 0.75 mcg/kgNumber of Participants With Postoperative ComplicationsVomiting0 Participants
Dexmedetomidine 0.75 mcg/kgNumber of Participants With Postoperative ComplicationsNausea2 Participants
Dexmedetomidine 1mcg/kgNumber of Participants With Postoperative ComplicationsVomiting0 Participants
Dexmedetomidine 1mcg/kgNumber of Participants With Postoperative ComplicationsNausea0 Participants
Morphine 50 mcg/kgNumber of Participants With Postoperative ComplicationsNausea0 Participants
Morphine 50 mcg/kgNumber of Participants With Postoperative ComplicationsVomiting0 Participants
Morphine 100mcg/kgNumber of Participants With Postoperative ComplicationsNausea3 Participants
Morphine 100mcg/kgNumber of Participants With Postoperative ComplicationsVomiting2 Participants
Secondary

Time to PACU Discharge Readiness

Patients were considered ready for discharge from the PACU when they attained an Aldrete score of 9 or more and were free from pain, nausea, and vomiting. Aldrete score ranges form 0 to 10 and patients greater than 8 are deemed satisfactory for discharge from the PACU

Time frame: From admission to discharge from PACU, no time limit

ArmMeasureValue (MEAN)Dispersion
Dexmedetomidine 0.75 mcg/kgTime to PACU Discharge Readiness115 minutesStandard Deviation 0.04
Dexmedetomidine 1mcg/kgTime to PACU Discharge Readiness116 minutesStandard Deviation 0.03
Morphine 50 mcg/kgTime to PACU Discharge Readiness117 minutesStandard Deviation 0.03
Morphine 100mcg/kgTime to PACU Discharge Readiness122 minutesStandard Deviation 0.06

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026